Inspire Medical Systems Earnings & Forecasts

Inspire Medical Systems (INSP) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

四半期利益の驚きの金額

会計四半期	報告日	実質EPS	推定EPS	驚き％
Q2	Aug 3, 2026	$0.14	$-0.24	158.3 %
Q1	May 4, 2026	$0.10	$-0.28	135.7 %
Q4	Feb 11, 2026	$1.65	$0.69	139.1 %
Q3	Nov 3, 2025	$0.38	$-0.14	371.4 %

Quarterly Revenue (Billions)

四半期売上高の驚きの金額

会計四半期	報告日	実際の収益	推定収益	驚き％
Q2	Aug 3, 2026	$200.58M	$194.70M	3.02 %
Q1	May 4, 2026	$204.58M	$199.77M	2.41 %
Q4	Feb 11, 2026	$269.08M	$267.33M	0.65 %
Q3	Nov 3, 2025	$224.50M	$220.61M	1.76 %

Inspire Medical Systems Guidance

Inspire Medical Systems (INSP) は、8 3, 2026 年に fiscal year 2026 のガイダンスを最後に発表しました。同社は 1 株当たり利益を $1.05 - $1.45 の範囲と予想し、コンセンサス EPS 予想は $0.91 でした。Inspire Medical Systems も、この期間の売上高を $835M - $875M の範囲と予想しました。

以前のガイダンスと比較すると、Inspire Medical SystemsはEPS見通しを以前の範囲である引き上げから$0.75 - $1.25に引き上げました。売上高については、同社は売上高予測を以前の範囲である維持から$825M - $875Mに引き上げました。

Inspire Medical Systemsは、30から11 1, 2022の間に8 3, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 15 times and lowered it 7 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$-0.24	$-0.28	$0.69	$-0.14
Actual	$0.14	$0.10	$1.65	$0.38
Surprise	+158.3%	+135.7%	+139.1%	+371.4%
Revenue
Estimate	$194.7M	$199.8M	$267.3M	$220.6M
Actual	$200.6M	$204.6M	$269.1M	$224.5M
Surprise	+3.02%	+2.41%	+0.65%	+1.76%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$0.09	$0.90	$0.17	$0.23
Revenue
Consensus	$204.1M	$244.4M	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results

INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock jumps 14.6% in pre-market trading. #INSP

Avi Kapoor

PRO
Inspire Medical Systems Lowers FY2026 GAAP EPS Guidance from $0.07-$0.62 to $(0.42)-$0.17 vs $0.90 Est

Inspire Medical Systems (NYSE:INSP) lowers FY2026 GAAP EPS guidance from $0.07-$0.62 to $(0.42)-$0.17 vs $0.90 analyst estimate..

Benzinga Newsdesk

PRO
Inspire Medical Systems Raises FY2026 Adj EPS Guidance from $0.75-$1.25 to $1.05-$1.45 vs $0.38 Est; Raises FY2026 Sales Guidance from $825.000M-$875.000M to $835.000M-$875.000M vs $843.387M Est

Inspire Medical Systems (NYSE:INSP) raises FY2026 Adj EPS guidance from $0.75-$1.25 to $1.05-$1.45 vs $0.38 analyst estimate. Raises FY2026 sales outlook from $825.000 million-$875.000 million to $835.000

Benzinga Newsdesk

PRO
Inspire Medical Systems Q2 Adj. EPS $0.14 Beats $(0.27) Estimate, Sales $200.581M Beat $194.671M Estimate

Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $(0.27) by 151.85 percent. This is a 58.82 percent decrease over earnings of $0.34 per

Benzinga Newsdesk

Stock Market Today: Dow, S&P 500, Nasdaq Futures Rise As Traders Monitor US-Iran Ceasefire— Duolingo, Pinterest, AMD In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the story.)

Rishabh Mishra

PRO
Inspire Medical Systems Lowers FY2026 GAAP EPS Guidance from $1.23-$1.81 to $0.07-$0.62 vs $1.63 Est

Inspire Medical Systems (NYSE:INSP) lowers FY2026 GAAP EPS guidance from $1.23-$1.81 to $0.07-$0.62 vs $1.63 analyst estimate..

Benzinga Newsdesk

Inspire Medical Systems Inc